UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
![]() |
|||||||
|
Fusion Protein:MED1-KRT222 |
Fusion Protein Summary |
![]() |
Fusion partner gene information | Fusion gene name: MED1-KRT222 | FusionPDB ID: 52656 | FusionGDB2.0 ID: 52656 | Hgene | Tgene | Gene symbol | MED1 | KRT222 | Gene ID | 8930 | 125113 |
Gene name | methyl-CpG binding domain 4, DNA glycosylase | keratin 222 | |
Synonyms | MED1 | KA21|KRT222P | |
Cytomap | 3q21.3 | 17q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | methyl-CpG-binding domain protein 43,N(4)-ethenocytosine glycosylaseG/5-fluorouracil mismatch glycosylase with biphasic kineticsG/T mismatch glycosylaseG/U mismatch glycosylasemethyl-CpG binding domain protein 4methyl-CpG-binding endonuclease 1meth | keratin-like protein KRT222keratin 222, type IIkeratin-222 pseudogene | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | A0JLT2 | . | |
Ensembl transtripts involved in fusion gene | ENST ids | ENST00000300651, ENST00000394287, | ENST00000394052, ENST00000476049, |
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 42 X 23 X 11=10626 | 7 X 5 X 5=175 |
# samples | 41 | 10 | |
** MAII score | log2(41/10626*10)=-4.69583089796762 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(10/175*10)=-0.807354922057604 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context (manual curation of fusion genes in FusionPDB) | PubMed: MED1 [Title/Abstract] AND KRT222 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | MED1(37604051)-KRT222(38818296), # samples:5 | ||
Anticipated loss of major functional domain due to fusion event. | MED1-KRT222 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. MED1-KRT222 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
Top |
Fusion Gene Sample Information |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | SKCM | TCGA-ER-A2NF-01A | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - |
ChimerDB4 | SKCM | TCGA-ER-A2NF-06A | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - |
Top |
Fusion ORF Analysis |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000394287 | MED1 | chr17 | 37604051 | - | ENST00000476049 | KRT222 | chr17 | 38818296 | - | 2702 | 338 | 1682 | 2701 | 340 |
ENST00000394287 | MED1 | chr17 | 37604051 | - | ENST00000394052 | KRT222 | chr17 | 38818296 | - | 1302 | 338 | 206 | 1129 | 307 |
ENST00000300651 | MED1 | chr17 | 37604051 | - | ENST00000476049 | KRT222 | chr17 | 38818296 | - | 2720 | 356 | 1700 | 2719 | 340 |
ENST00000300651 | MED1 | chr17 | 37604051 | - | ENST00000394052 | KRT222 | chr17 | 38818296 | - | 1320 | 356 | 224 | 1147 | 307 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000394287 | ENST00000476049 | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - | 0.003252878 | 0.99674714 |
ENST00000394287 | ENST00000394052 | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - | 0.001652611 | 0.9983474 |
ENST00000300651 | ENST00000476049 | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - | 0.003160406 | 0.99683964 |
ENST00000300651 | ENST00000394052 | MED1 | chr17 | 37604051 | - | KRT222 | chr17 | 38818296 | - | 0.001483366 | 0.9985166 |
Top |
Fusion Amino Acid Sequences |
![]() |
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >52656_52656_1_MED1-KRT222_MED1_chr17_37604051_ENST00000300651_KRT222_chr17_38818296_ENST00000394052_length(amino acids)=307AA_BP=44 MKAQGETEESEKLSKMSSLLERLHAKFNQNRPWSETIKLVRQVMLEEDISKKMDKDEEALKAAQAELKEARRQWHHLQVEIESLHAVERG LENSLHASEQHYQMQLQDLETVIEGLEKELQEVRRGIEKQLQEHEMLLNTKMRLEQEIATYRHLLEKEEIRYYGCIQGGKKDKKPTTSRV GFVLPSAIINEISFTTKVPQKYENENVETVTKQAILNGSIVKESTEAHGTIQTEKVDEVIKEWEGSFFKDNPRLRKKSVSLRFDLHLAAT -------------------------------------------------------------- >52656_52656_2_MED1-KRT222_MED1_chr17_37604051_ENST00000300651_KRT222_chr17_38818296_ENST00000476049_length(amino acids)=340AA_BP= MVGTEGAEAALRRRPVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESR QRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQI EERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENI -------------------------------------------------------------- >52656_52656_3_MED1-KRT222_MED1_chr17_37604051_ENST00000394287_KRT222_chr17_38818296_ENST00000394052_length(amino acids)=307AA_BP=44 MKAQGETEESEKLSKMSSLLERLHAKFNQNRPWSETIKLVRQVMLEEDISKKMDKDEEALKAAQAELKEARRQWHHLQVEIESLHAVERG LENSLHASEQHYQMQLQDLETVIEGLEKELQEVRRGIEKQLQEHEMLLNTKMRLEQEIATYRHLLEKEEIRYYGCIQGGKKDKKPTTSRV GFVLPSAIINEISFTTKVPQKYENENVETVTKQAILNGSIVKESTEAHGTIQTEKVDEVIKEWEGSFFKDNPRLRKKSVSLRFDLHLAAT -------------------------------------------------------------- >52656_52656_4_MED1-KRT222_MED1_chr17_37604051_ENST00000394287_KRT222_chr17_38818296_ENST00000476049_length(amino acids)=340AA_BP= MVGTEGAEAALRRRPVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESR QRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQI EERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENI -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr17:37604051/chr17:38818296) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
MED1 | . |
FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
![]() |
- Retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- Not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 1078_1482 | 44.0 | 1582.0 | Compositional bias | Note=Ser-rich |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 1496_1529 | 44.0 | 1582.0 | Compositional bias | Note=Lys-rich |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 1078_1482 | 44.0 | 557.0 | Compositional bias | Note=Ser-rich |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 1496_1529 | 44.0 | 557.0 | Compositional bias | Note=Lys-rich |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 604_608 | 44.0 | 1582.0 | Motif | Note=LXXLL motif 1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 645_649 | 44.0 | 1582.0 | Motif | Note=LXXLL motif 2 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 875_902 | 44.0 | 1582.0 | Motif | Integrase domain-binding motif (IBM) |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 604_608 | 44.0 | 557.0 | Motif | Note=LXXLL motif 1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 645_649 | 44.0 | 557.0 | Motif | Note=LXXLL motif 2 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 875_902 | 44.0 | 557.0 | Motif | Integrase domain-binding motif (IBM) |
Tgene | KRT222 | chr17:37604051 | chr17:38818296 | ENST00000394052 | 0 | 6 | 2_150 | 32.0 | 296.0 | Coiled coil | Ontology_term=ECO:0000255 | |
Tgene | KRT222 | chr17:37604051 | chr17:38818296 | ENST00000394052 | 0 | 6 | 1_150 | 32.0 | 296.0 | Domain | IF rod |
Top |
Fusion Protein Structures |
![]() * Here we show the 3D structure of the fusion proteins using Mol*. AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. Model confidence is shown from the pLDDT values per residue. pLDDT corresponds to the model’s prediction of its score on the local Distance Difference Test. It is a measure of local accuracy (from AlphfaFold website). To color code individual residues, we transformed individual PDB files into CIF format. |
Fusion protein PDB link (fusion AA seq ID in FusionPDB) | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | AA seq | Len(AA seq) |
PDB file >>>646_MED1_37604051_KRT222_38818296_ranked_0.pdb | MED1 | 37604051 | 37604051 | ENST00000394052 | KRT222 | chr17 | 38818296 | - | MVGTEGAEAALRRRPVKASNPDLKLWEIGKIIGGMWRDLTDEEKQEYLNEYEAEKIEYNESMKAYHNSPAYLAYINAKSRAEAALEEESR QRQSRMEKGEPYMSIQPAEDPDDYDDGFSMKHTATARFQRNHRLISEILSESVVPDVRSVVTTARMQVLKRQVQSLMVHQRKLEAELLQI EERHQEKKRKFLESTDSFNNELKRLCGLKVEVDMEKIAAEIAQAEEQARKRQEEREKEAAEQAERSQSSIVPEEEQAANKGEEKKDDENI | 340 |
Top |
pLDDT score distribution |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
MED1_pLDDT.png![]() |
KRT222_pLDDT.png![]() |
![]() * AlphaFold produces a per-residue confidence score (pLDDT) between 0 and 100. |
![]() |
Top |
Ramachandran Plot of Fusion Protein Structure |
![]() |
Fusion AA seq ID in FusionPDB and their Ramachandran plots |
Top |
Fusion Protein-Protein Interaction |
![]() |
![]() |
Gene | PPI interactors |
![]() |
Gene | STRING network |
MED1 | |
KRT222 |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 16_590 | 44.0 | 1582.0 | ESR1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 656_1066 | 44.0 | 1582.0 | ESR1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 16_590 | 44.0 | 557.0 | ESR1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 656_1066 | 44.0 | 557.0 | ESR1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 681_715 | 44.0 | 1582.0 | GATA1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 681_715 | 44.0 | 557.0 | GATA1 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 622_701 | 44.0 | 1582.0 | PPARGC1A and THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 622_701 | 44.0 | 557.0 | PPARGC1A and THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 108_212 | 44.0 | 1582.0 | the Mediator complex |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 215_390 | 44.0 | 1582.0 | the Mediator complex |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 108_212 | 44.0 | 557.0 | the Mediator complex |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 215_390 | 44.0 | 557.0 | the Mediator complex |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 1_670 | 44.0 | 1582.0 | the Mediator complex and THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 1_670 | 44.0 | 557.0 | the Mediator complex and THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 405_644 | 44.0 | 1582.0 | THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 405_644 | 44.0 | 557.0 | THRA |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 1249_1421 | 44.0 | 1582.0 | TP53 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 1249_1421 | 44.0 | 557.0 | TP53 |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000300651 | - | 2 | 17 | 542_789 | 44.0 | 1582.0 | VDR |
Hgene | MED1 | chr17:37604051 | chr17:38818296 | ENST00000394287 | - | 2 | 18 | 542_789 | 44.0 | 557.0 | VDR |
Top |
Related Drugs to MED1-KRT222 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to MED1-KRT222 |
![]() (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
Hgene | Tgene | Disease | Source | PMID |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |